Physician profile
Nitin N Katariya
NPI 1245412238
$26,304.56
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,788 · 2020: $340 · 2021: $235 · 2022: $213 · 2023: $2,030 · 2024: $5,958 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $6,431 · Food and Beverage: $2,597 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,200.00 |
| Travel and Lodging | $6,431.27 |
| Food and Beverage | $2,596.85 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17,433.84 | 2023-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Therasphere Y90 Glass Microspheres 10 Gbq |
| Intuitive Surgical, INC. | $7,121.46 | 2019-2024 | Da Vinci Surgical System |
| Dilon Technologies, INC. | $336.40 | 2024-2025 | Hemoblast Bellows |
| Paragonix Technologies, INC. | $280.94 | 2024 | Pancreaspak, Sherpapak, Lungguard |
| Medtronic, INC. | $261.33 | 2023-2025 | Signia |
| Histosonics, INC. | $235.00 | 2024 | |
| Davol INC. | $151.86 | 2019 | |
| Integra Lifesciences Corporation | $143.64 | 2020 | |
| Veloxis Pharmaceuticals, INC. | $124.01 | 2019 | |
| Sanofi-Aventis U.S. LLC | $123.89 | 2021 | |
| Conmed Corporation | $75.18 | 2019 | |
| Chiesi USA, INC. | $17.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Katariya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.